S3v Vascular Technologies Annual Reports, Balance Sheet and Financials

S3V Vascular Technologies Limited Standalone Balance Sheet (Rs. in crores).

S3V Vascular Technologies Limited Standalone Profit & Loss Statement (Rs. in crores).

S3V Vascular Technologies Limited Standalone Cash Flow Statement (Rs. in crores).

Summary of the Cash Flow Statement for the years 2025 and 2024:

Cash Flow from Operating Activities
The company’s operating performance remains weak despite some improvement. Profit before tax turned positive at ₹0.16 crore in FY2025 compared to a loss of ₹-3.06 crore in FY2024, indicating initial signs of recovery. However, cash flow from operations is still negative at ₹-6.42 crore, though slightly better than ₹-7.33 crore in the previous year. Major non-cash adjustments such as depreciation (₹2.20 crore) and provision for doubtful debts (₹0.71 crore) supported cash flow, but were outweighed by adverse working capital movements. Significant increases in trade receivables (₹5.10 crore) and inventories (₹5.54 crore) indicate funds being locked in operations. Although loans and advances showed some improvement, overall working capital management continues to strain liquidity, resulting in negative operating cash flow.

Cash Flow from Investing Activities
Investing activities show continued heavy outflows, with ₹-31.14 crore in FY2025 compared to ₹-30.25 crore in FY2024. The primary driver is substantial capital expenditure on asset purchases (₹53.24 crore), indicating ongoing expansion or modernization efforts. This was partially offset by maturity of bank deposits (₹19.79 crore) and interest income (₹2.31 crore). Despite these inflows, the net outflow remains significant, reflecting sustained investment intensity which may support future growth but is currently putting pressure on cash reserves.

Cash Flow from Financing Activities
Financing activities reflect a sharp contrast compared to the previous year. In FY2024, the company raised substantial funds through equity issuance (₹104.88 crore), resulting in strong positive cash flow. However, in FY2025, there were no such inflows, and cash flow turned negative at ₹-9.80 crore. This was primarily due to repayment of long-term borrowings (₹9.53 crore) and interest payments. The absence of fresh funding coupled with ongoing debt servicing has reduced financial inflows, increasing reliance on internal cash generation, which remains weak.

Net Increase/decrease in Cash & Cash equivalents
The overall cash position deteriorated significantly, with a net decrease of ₹-47.37 crore in FY2025 compared to a strong increase of ₹54.97 crore in FY2024. As a result, closing cash and cash equivalents dropped sharply to ₹9.17 crore from ₹56.54 crore. This decline is driven by negative operating cash flows, heavy capital expenditure, and lack of financing inflows during the year. The sharp reduction in cash reserves raises concerns about liquidity and highlights the need for improved operational efficiency and possibly additional funding to sustain ongoing investments

Financial ratios of S3V Vascular Technologies Limited.

Summary of Financial Ratio of the year 2025 and 2024.

Current Ratio
The current ratio declined to 3.17 in FY2025 from 4.33 in FY2024, indicating a reduction in short-term liquidity. Although the ratio is still comfortably above 1, suggesting the company can meet its short-term obligations, the decline reflects a decrease in the cushion of current assets over current liabilities. This may be linked to the reduction in cash balances during the year.

Debt Equity Ratio
The debt-equity ratio improved to 0.13 from 0.18, indicating lower reliance on debt financing. This reflects a conservative capital structure with minimal financial risk. The reduction is likely due to repayment of borrowings and the strong equity base built in the previous year.

Debt Service Coverage Ratio
The debt service coverage ratio dropped sharply to 0.00 from 0.30, indicating the company is currently unable to generate sufficient operating income to meet its debt servicing obligations. This is a concerning sign and highlights weak operating performance despite a marginal improvement in profitability.

Return on Equity
Return on equity improved to 0.05% from -3.56%, showing a turnaround from negative to slightly positive returns for shareholders. However, the return remains extremely low, indicating inefficient utilization of shareholders’ funds and limited profitability.

Inventory Turnover Ratio
The inventory turnover ratio declined significantly to 0.21 from 0.55, indicating very slow movement of inventory. This suggests excess stock holding or weak sales, leading to inefficient use of working capital and increased holding costs.

Trade Account Receivables Ratio
The receivables turnover ratio decreased to 0.34 from 0.42, reflecting slower collection from customers. This indicates weakening credit management and contributes to cash flow constraints, as more funds are tied up in receivables.

Trade Account Payables Ratio
The payables turnover ratio declined to 1.33 from 1.92, suggesting the company is taking longer to pay its suppliers. While this may provide temporary relief to cash flow, it may also strain supplier relationships if prolonged.

Net Capital Turnover Ratio
The net capital turnover ratio improved to 0.26 from 0.17, indicating better utilization of capital to generate revenue. However, the ratio remains low, suggesting that overall efficiency in using capital is still limited.

Net Profit Ratio
The net profit ratio improved significantly to 0.40% from -21.09%, indicating a strong recovery from heavy losses to marginal profitability. Despite this improvement, margins remain very thin, pointing to continued cost pressures or low pricing power.

Return on Capital Employed
Return on capital employed slightly declined to 0.34% from 0.41%, indicating marginally lower efficiency in generating returns from total capital employed. The low percentage suggests that the company is still struggling to generate adequate returns from its invested capital.